TY  - JOUR
AU  - Calleja, Miguel Ángel
AU  - Badia, Xavier
PY  - 2022
DO  - 10.1017/S0266462322000332
UR  - http://hdl.handle.net/10668/22577
T2  - International journal of technology assessment in health care
AB  - The reimbursement of medicines by the Spanish National Health System (NHS) is based on a set of criteria included in the Royal Legislative Decree 1/2015 (RDL 1/2015). The Interministerial Committee on Pricing of Medicines and Healthcare Products...
LA  - en
KW  - Cefiderocol
KW  - Drug evaluation
KW  - P&R criteria characterization
KW  - P&R decision-making criteria
KW  - Pricing and reimbursement
KW  - Cephalosporins
KW  - Costs and Cost Analysis
KW  - Europe
KW  - Feasibility Studies
KW  - Technology Assessment, Biomedical
TI  - Feasibility study to characterize price and reimbursement decision-making criteria for the inclusion of new drugs in the Spanish National Health System: the cefiderocol example.
TY  - research article
VL  - 38
ER  -